JNJ.CI

Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs · BCBA:JNJ.CI

30,900.00 ARS1,060.00 +3.55%

Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs (BCBA:JNJ.CI) last traded at 30,900.00 ARS, up 3.55% on the day. Over the past year the stock is up 61.61%. Its 52-week range is 18,060.00 to 31,000.00. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open30,160.00

Day range29,940.00 – 30,920.00

52-week range18,060.00 – 31,000.00

Volume781

Average volume (10 days)771

Market cap (USD)640.75 B

P/E49.45

EPS (TTM) (USD)0.4093

Dividend yield1.11%

Beta (1 year)−0.0809

Revenue (TTM) (USD)93.79 B

Employees140.80 K

Performance

+5.03%1 week

+12.86%1 month

+9.65%3 months

+38.88%6 months

+47.14%Year to date

+61.61%1 year

Technical reading

Strongly bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Smith+Nephew cuts outlook, confirms failed merger talks with J&J's orthopaedics unitReuters · 04 Nov 2026
How health care is on the ballot in the midtermsSeeking Alpha · 03 Nov 2026
Most and least shorted mid- to mega-cap healthcare stocks at the end of OctoberSeeking Alpha · 03 Nov 2026
Johnson & Johnson reports 94% success rate in trial of coronary artery deviceSeeking Alpha · 01 Nov 2026
Johnson & Johnson reports lower mortality rates with Impella heart pumpsSeeking Alpha · 01 Nov 2026
J&J Reports Positive Survival And Outcomes With Impella In HrpciReuters · 01 Nov 2026
Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study ResultsBusinessWire · 01 Nov 2026
Ayushman Bharat Digital Mission Can Transform Healthcare Through Data, Says NITI Aayog MemberBusinessworld · 01 Nov 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.